FDA Early Alert Issued for Abiomed Impella Controllers
The US Food and Drug Administration has shared an early alert regarding an action by Abiomed to remove certain Automated Impella Controllers for hardware, firmware, and software updates. A retrospective review of servicing records identified potential quality issues that could impact device operation.
Affected models include specific serial numbers of the Impella Controller, Packaged, US, the Impella Optical Controller, Packaged, US, and the Optical, AIC, Impella Controller, Packaged, US. Identified quality concerns include failure to recognize the purge cassette during setup, buttons that may stick or prove unreliable, start-up instability, and other software defects which could potentially lead to delayed therapy or loss of hemodynamic support if left unaddressed. No serious injuries or deaths have been reported in connection with this issue.
Abiomed is contacting affected customers to coordinate the removal, updating, and return of the devices. The manufacturer advises that current hospital inventory may continue to be used while awaiting service to ensure continuity of care.
Key points
- Abiomed is removing certain Automated Impella Controllers for hardware, firmware, and software updates following a retrospective service record review.
- Potential issues include failure to recognize purge cassettes, sticking buttons, start-up instability, and software defects.
- Unaddressed issues could lead to delayed therapy, inadequate support, or loss of hemodynamic control.
- Hospitals may continue using current device inventory while awaiting service to maintain continuity of care.
What it means for you
Clinicians and hospital staff using Abiomed Impella systems should be aware of this early alert regarding controller updates and coordinate with the manufacturer for servicing. Healthcare professionals in Pakistan should check with local suppliers or the Drug Regulatory Authority of Pakistan to determine if the affected controller models are registered or in use locally and to follow any specific domestic guidance.
Early Alert: Heart Pump Controller Issue from Abiomed
Summarised automatically from the official announcement. For educational purposes only — check the original source before making clinical decisions.